Sale!

DDHD1 Gene SPG28 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DDHD1 gene SPG28 genetic test is a specialized diagnostic tool designed to detect mutations in the DDHD1 gene, which are associated with a rare form of hereditary spastic paraplegia (HSP), specifically SPG28. HSPs are a group of inherited disorders characterized by progressive stiffness and contraction (spasticity) in the lower limbs, and SPG28 is one of its autosomal recessive subtypes.

This genetic test involves analyzing the patient’s DNA to identify any alterations in the DDHD1 gene that may lead to the disease. It is a crucial step in confirming the diagnosis of SPG28, allowing for a better understanding of the condition, informed genetic counseling, and personalized management plans for affected individuals.

The test is offered by DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the DDHD1 gene SPG28 genetic test is 4400 AED. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of the test results, providing essential insights for patients and their families dealing with the challenges of hereditary spastic paraplegia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DDHD1 Gene SPG28 Genetic Test

Welcome to DNA Labs UAE, where we offer the DDHD1 Gene SPG28 Genetic Test for individuals with suspected hereditary spastic paraplegia type 28 (SPG28). This test can help diagnose the condition and provide valuable information for genetic counseling and management.

Test Details

The DDHD1 gene is associated with hereditary spastic paraplegia type 28 (SPG28), a condition characterized by progressive weakness and stiffness of the legs. This is caused by the degeneration of nerve fibers controlling muscle movement in the lower limbs. Our Next-Generation Sequencing (NGS) technology allows us to analyze multiple genes simultaneously to identify variations or mutations in the DDHD1 gene that may be causing the condition.

Components

  • Test Name: DDHD1 Gene SPG28 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the DDHD1 Gene SPG28 Genetic Test, it is important to provide the clinical history of the patient. This includes any relevant information about the symptoms and family history of the condition. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by SPG28.

Benefits of the DDHD1 Gene SPG28 Genetic Test

  • Accurate diagnosis of hereditary spastic paraplegia type 28
  • Determination of the inheritance pattern of the condition
  • Identification of genetic variations or mutations in the DDHD1 gene
  • Appropriate genetic counseling and management options for affected individuals and their families

If you suspect that you or a loved one may have hereditary spastic paraplegia type 28, our DDHD1 Gene SPG28 Genetic Test can provide valuable insights. Contact DNA Labs UAE today to schedule an appointment.

Test Name DDHD1 Gene SPG28 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DDHD1 Gene SPG28 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DDHD1 Gene SPG28
Test Details

The DDHD1 gene is associated with a condition called hereditary spastic paraplegia type 28 (SPG28). This condition is characterized by progressive weakness and stiffness of the legs (spastic paraplegia) due to the degeneration of the nerve fibers that control muscle movement in the lower limbs.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular condition or disease. In the case of SPG28, NGS genetic testing can be used to identify variations or mutations in the DDHD1 gene that may be causing the condition.

By identifying these genetic variations, healthcare providers can provide a more accurate diagnosis, determine the inheritance pattern of the condition, and offer appropriate genetic counseling and management options for affected individuals and their families.